330 related articles for article (PubMed ID: 15345806)
1. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models.
Baum L; Ng A
J Alzheimers Dis; 2004 Aug; 6(4):367-77; discussion 443-9. PubMed ID: 15345806
[TBL] [Abstract][Full Text] [Related]
2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
3. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
4. Current status of metals as therapeutic targets in Alzheimer's disease.
Finefrock AE; Bush AI; Doraiswamy PM
J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
[TBL] [Abstract][Full Text] [Related]
5. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
6. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
[TBL] [Abstract][Full Text] [Related]
7. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
[TBL] [Abstract][Full Text] [Related]
8. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta metal interaction and metal chelation.
Cuajungco MP; Frederickson CJ; Bush AI
Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
[TBL] [Abstract][Full Text] [Related]
10. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
11. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
Cuajungco MP; Fagét KY
Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
[TBL] [Abstract][Full Text] [Related]
12. Syntheses And Evaluation Of Asymmetric Curcumin Analogues As Potential Multifunctional Agents For The Treatment Of Alzheimer's Disease.
Zhai P; Xia CL; Tan JH; Li D; Ou TM; Huang SL; Gu LQ; Huang ZS
Curr Alzheimer Res; 2015; 12(5):403-14. PubMed ID: 25938868
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
[TBL] [Abstract][Full Text] [Related]
14. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
15. Metal chelation, radical scavenging and inhibition of Aβ₄₂ fibrillation by food constituents in relation to Alzheimer's disease.
Chan S; Kantham S; Rao VM; Palanivelu MK; Pham HL; Shaw PN; McGeary RP; Ross BP
Food Chem; 2016 May; 199():185-94. PubMed ID: 26775960
[TBL] [Abstract][Full Text] [Related]
16. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
17. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
18. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
19. Metal chelation as a potential therapy for Alzheimer's disease.
Cuajungco MP; Fagét KY; Huang X; Tanzi RE; Bush AI
Ann N Y Acad Sci; 2000; 920():292-304. PubMed ID: 11193167
[TBL] [Abstract][Full Text] [Related]
20. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
